Joon Lee
Stock Analyst at Truist Securities
(4.32)
# 472
Out of 4,479 analysts
87
Total ratings
44.59%
Success rate
20.58%
Average return
Main Sectors:
Top Industries:
21 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARGX argenx SE | Maintains: Buy | $440 → $480 | $435.49 | +10.22% | 9 | Jun 25, 2024 | |
| NTLA Intellia Therapeutics | Maintains: Buy | $120 | $22.15 | +441.76% | 3 | Jun 24, 2024 | |
| MRNS Marinus Pharmaceuticals | Maintains: Buy | $10 | $1.19 | +740.34% | 7 | Jun 18, 2024 | |
| VKTX Viking Therapeutics | Maintains: Buy | $120 | $51.54 | +132.83% | 7 | Jun 17, 2024 | |
| CORT Corcept Therapeutics | Maintains: Buy | $65 | $31.56 | +105.96% | 6 | Jun 17, 2024 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $150 | $39.27 | +281.97% | 3 | May 16, 2024 | |
| ADVM Adverum Biotechnologies | Maintains: Buy | $60 | $6.84 | +777.19% | 5 | May 15, 2024 | |
| SAGE Sage Therapeutics | Maintains: Hold | $22 → $18 | $10.82 | +66.36% | 5 | Apr 26, 2024 | |
| WVE Wave Life Sciences | Reiterates: Buy | $17 | $5.22 | +225.67% | 2 | Apr 1, 2024 | |
| AXSM Axsome Therapeutics | Maintains: Buy | $150 | $78.93 | +90.04% | 2 | Mar 26, 2024 | |
| ARVN Arvinas | Reiterates: Buy | $65 | $24.85 | +161.57% | 5 | Mar 25, 2024 | |
| JAZZ Jazz Pharmaceuticals | Reiterates: Buy | $200 | $105.09 | +90.31% | 2 | Mar 20, 2024 | |
| CRMD CorMedix | Maintains: Buy | $18 → $14 | $4.12 | +239.81% | 4 | Jan 31, 2024 | |
| EDIT Editas Medicine | Maintains: Buy | $15 → $20 | $4.54 | +340.53% | 5 | Dec 12, 2023 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $220 → $160 | $53.12 | +201.23% | 3 | Dec 11, 2023 | |
| TSHA Taysha Gene Therapies | Maintains: Buy | $6 → $5 | $2.16 | +131.48% | 7 | Sep 20, 2023 | |
| VRNA Verona Pharma | Reiterates: Buy | $32 | $15.46 | +106.99% | 3 | Jun 27, 2023 | |
| CPRX Catalyst Pharmaceuticals | Maintains: Buy | $22 → $24 | $15.80 | +51.90% | 5 | Jun 21, 2023 | |
| VYGR Voyager Therapeutics | Initiates: Buy | $18 | $7.59 | +137.15% | 1 | May 10, 2023 | |
| TBIO Telesis Bio | Downgrades: Hold | $360 | $3.74 | +9,525.67% | 2 | Mar 18, 2021 | |
| ANAB AnaptysBio | Upgrades: Buy | n/a | $23.94 | - | 1 | Mar 16, 2021 |
argenx SE
Jun 25, 2024
Maintains: Buy
Price Target: $440 → $480
Current: $435.49
Upside: +10.22%
Intellia Therapeutics
Jun 24, 2024
Maintains: Buy
Price Target: $120
Current: $22.15
Upside: +441.76%
Marinus Pharmaceuticals
Jun 18, 2024
Maintains: Buy
Price Target: $10
Current: $1.19
Upside: +740.34%
Viking Therapeutics
Jun 17, 2024
Maintains: Buy
Price Target: $120
Current: $51.54
Upside: +132.83%
Corcept Therapeutics
Jun 17, 2024
Maintains: Buy
Price Target: $65
Current: $31.56
Upside: +105.96%
Praxis Precision Medicines
May 16, 2024
Maintains: Buy
Price Target: $150
Current: $39.27
Upside: +281.97%
Adverum Biotechnologies
May 15, 2024
Maintains: Buy
Price Target: $60
Current: $6.84
Upside: +777.19%
Sage Therapeutics
Apr 26, 2024
Maintains: Hold
Price Target: $22 → $18
Current: $10.82
Upside: +66.36%
Wave Life Sciences
Apr 1, 2024
Reiterates: Buy
Price Target: $17
Current: $5.22
Upside: +225.67%
Axsome Therapeutics
Mar 26, 2024
Maintains: Buy
Price Target: $150
Current: $78.93
Upside: +90.04%
Arvinas
Mar 25, 2024
Reiterates: Buy
Price Target: $65
Current: $24.85
Upside: +161.57%
Jazz Pharmaceuticals
Mar 20, 2024
Reiterates: Buy
Price Target: $200
Current: $105.09
Upside: +90.31%
CorMedix
Jan 31, 2024
Maintains: Buy
Price Target: $18 → $14
Current: $4.12
Upside: +239.81%
Editas Medicine
Dec 12, 2023
Maintains: Buy
Price Target: $15 → $20
Current: $4.54
Upside: +340.53%
CRISPR Therapeutics AG
Dec 11, 2023
Maintains: Buy
Price Target: $220 → $160
Current: $53.12
Upside: +201.23%
Taysha Gene Therapies
Sep 20, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $2.16
Upside: +131.48%
Verona Pharma
Jun 27, 2023
Reiterates: Buy
Price Target: $32
Current: $15.46
Upside: +106.99%
Catalyst Pharmaceuticals
Jun 21, 2023
Maintains: Buy
Price Target: $22 → $24
Current: $15.80
Upside: +51.90%
Voyager Therapeutics
May 10, 2023
Initiates: Buy
Price Target: $18
Current: $7.59
Upside: +137.15%
Telesis Bio
Mar 18, 2021
Downgrades: Hold
Price Target: $360
Current: $3.74
Upside: +9,525.67%
AnaptysBio
Mar 16, 2021
Upgrades: Buy
Price Target: n/a
Current: $23.94
Upside: -